Orthopediatrics (KIDS) Non-Current Deffered Revenue (2019)
Orthopediatrics' (KIDS) quarterly Non-Current Deffered Revenue came in at $12.4 million in Q4 2019.
Orthopediatrics (KIDS) Non-Current Deffered Revenue (2019) Analysis & Trends
Orthopediatrics (KIDS) has 1 years of Non-Current Deffered Revenue data on file, last reported at $12.4 million in Q4 2019.
- On a quarterly basis, Non-Current Deffered Revenue changed N/A year-over-year to $12.4 million in Q4 2019; TTM through Dec 2019 was $12.4 million, a N/A change from a year earlier, with the FY2019 full-year figure at $12.4 million, changed N/A from the prior year.
- Non-Current Deffered Revenue for Q4 2019 stood at $12.4 million.
- Over the last five years, Non-Current Deffered Revenue for KIDS reached as high as $12.4 million in Q4 2019 and fell as low as $12.4 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn | - |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn | 512.79 Mn |
| 10 | Orthopediatrics | 461.15 Mn | 446.90 Mn | 43.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 12.41 Mn |